| scholarly article | Q13442814 |
| P50 | author | Florian Herse | Q47804678 |
| Gerd Wallukat | Q63288594 | ||
| Ralf Dechend | Q63812628 | ||
| P2093 | author name string | Babbette LaMarca | |
| Denise C Cornelius | |||
| Lorena M Amaral | |||
| Mark W Cunningham | |||
| Ashlyn C Harmon | |||
| Jessica L Faulkner | |||
| Tarek Ibrahim | |||
| Marie M Darby | |||
| D'Andrea S Thomas | |||
| P2860 | cites work | Elucidating immune mechanisms causing hypertension during pregnancy | Q26852668 |
| Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis | Q26862535 | ||
| What we have learned about preeclampsia | Q28196892 | ||
| Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats | Q28571017 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Nonclassic actions of vitamin D | Q33375907 | ||
| 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. | Q33606850 | ||
| Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia | Q33736407 | ||
| Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity | Q33748680 | ||
| Vitamin D supplementation during pregnancy: safety considerations in the design and interpretation of clinical trials | Q33799042 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Preeclampsia prevention and management | Q33872560 | ||
| Vitamin effects on the immune system: vitamins A and D take centre stage | Q34005584 | ||
| A Historical Overview of Preeclampsia‐Eclampsia | Q34181886 | ||
| A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia | Q34262439 | ||
| CD4(+) T Cells Play a Critical Role in Mediating Hypertension in Response to Placental Ischemia | Q34508485 | ||
| Vitamin D Supplementation Suppresses Hypoxia-Stimulated Placental Cytokine Secretion, Hypertension and CD4(+) T Cell Stimulation in Response to Placental Ischemia | Q34533258 | ||
| Maternal vitamin D deficiency increases the risk of preeclampsia | Q34579840 | ||
| Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes | Q35029700 | ||
| CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy | Q35130793 | ||
| 17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model | Q35151065 | ||
| Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction | Q35576417 | ||
| Elimination of vitamin D receptor in vascular endothelial cells alters vascular function | Q35601964 | ||
| Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
| Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia | Q35681821 | ||
| Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia | Q35715914 | ||
| 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region | Q35981603 | ||
| Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats | Q35994304 | ||
| Activating auto-antibodies against the AT1 receptor in preeclampsia | Q36010629 | ||
| Endothelin: key mediator of hypertension in preeclampsia | Q36073225 | ||
| Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. | Q36115279 | ||
| A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model | Q36115311 | ||
| Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation | Q36244980 | ||
| Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats | Q36339273 | ||
| An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia | Q36339336 | ||
| The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
| Free 25(OH)D and Calcium Absorption, PTH, and Markers of Bone Turnover | Q36433561 | ||
| Mechanisms of disease: Pre-eclampsia | Q36577103 | ||
| Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
| Immunoregulation in normal pregnancy and pre-eclampsia: an overview | Q36684096 | ||
| Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients | Q36795649 | ||
| IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia | Q36997267 | ||
| Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction | Q37022723 | ||
| The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia | Q37088970 | ||
| The two stage model of preeclampsia: variations on the theme | Q37187589 | ||
| Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy | Q37353537 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats | Q37449693 | ||
| Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. | Q37844756 | ||
| Different vitamin D receptor agonists exhibit differential effects on endothelial function and aortic gene expression in 5/6 nephrectomized rats | Q38286913 | ||
| MicroRNA-mediated mechanism of vitamin D regulation of innate immune response | Q38626414 | ||
| Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia | Q40028522 | ||
| Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions | Q40545992 | ||
| Discrimination in the metabolism of orally dosed ergocalciferol and cholecalciferol by the pig, rat and chick | Q41824991 | ||
| Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. | Q43576536 | ||
| Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia | Q46332630 | ||
| Effect of treatment of vitamin D deficiency and insufficiency during pregnancy on fetal growth indices and maternal weight gain: a randomized clinical trial. | Q47200959 | ||
| Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood | Q47890265 | ||
| Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. | Q50514586 | ||
| Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. | Q51973496 | ||
| Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. | Q52087250 | ||
| Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
| First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia | Q56619507 | ||
| Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
| CD19 + CD5 + Cells as Indicators of Preeclampsia | Q59906564 | ||
| Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months | Q60572282 | ||
| Vitamin D Supplementation and Reduced Risk of Preeclampsia in Nulliparous Women | Q62565327 | ||
| Prevention of preeclampsia with calcium supplementation and vitamin D3 in an antenatal protocol | Q72509768 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia | Q82705098 | ||
| P433 | issue | 4 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| vitamin D | Q175621 | ||
| P304 | page(s) | R346-54 | |
| P577 | publication date | 2015-12-16 | |
| P1433 | published in | American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | Q2201819 |
| P1476 | title | Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia | |
| P478 | volume | 310 |
| Q91564905 | Characterisation of the Selective Reduced Uteroplacental Perfusion (sRUPP) Model of Preeclampsia |
| Q38788258 | Meta-analysis of the effect of the maternal vitamin D level on the risk of spontaneous pregnancy loss |
| Q41540480 | New insights into the vitamin D requirements during pregnancy |
| Q104137018 | Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction |
| Q30382673 | Reduced Uterine Perfusion Pressure (RUPP) Model of Preeclampsia in Mice |
| Q57166484 | The Implications of Vitamin D Status During Pregnancy on Mother and her Developing Child |
| Q38953734 | Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications. |
| Q51318293 | Vitamin D restores angiogenic balance and decreases tumor necrosis factor-α in a rat model of pre-eclampsia. |
| Q51294484 | Vitamin D supplementation reduces some AT1-AA-induced downstream targets implicated in preeclampsia including hypertension. |
Search more.